"Myositis, Inclusion Body" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10)
| Descriptor ID |
D018979
|
| MeSH Number(s) |
C05.651.594.600 C10.668.491.562.500
|
| Concept/Terms |
Myositis, Inclusion Body- Myositis, Inclusion Body
- Inclusion Body Myositides
- Myositides, Inclusion Body
- Inclusion Body Myositis
Inclusion Body Myopathy, Sporadic- Inclusion Body Myopathy, Sporadic
- Myositis, Inclusion Body, Sporadic
- Myopathy, Inclusion Body, Sporadic
- Inclusion Body Myositis, Sporadic
- Sporadic Inclusion Body Myositis
|
Below are MeSH descriptors whose meaning is more general than "Myositis, Inclusion Body".
Below are MeSH descriptors whose meaning is more specific than "Myositis, Inclusion Body".
This graph shows the total number of publications written about "Myositis, Inclusion Body" by people in this website by year, and whether "Myositis, Inclusion Body" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myositis, Inclusion Body" by people in Profiles.
-
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. Neurology. 2021 03 23; 96(12):e1595-e1607.
-
Novel GNE mutations in two phenotypically distinct HIBM2 patients. Neuromuscul Disord. 2011 Feb; 21(2):102-5.
-
Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol. 2009 Dec 14; 187(6):875-88.
-
TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2008 Oct; 79(10):1186-9.
-
Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum Mol Genet. 2007 Apr 15; 16(8):919-28.
-
Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 1998 Apr; 41(4):710-9.